The stock appears to be inexpensive relative to next year's earnings estimates and earnings growth expectations while having great near- and long-term earnings growth estimates. The company pays a great dividend and has a phenomenal return on equity. The risk/reward ratio is tilted towards higher risk at this point but it is about equal.
AbbVie Inc (NYSE:ABBV) is a research-based biopharmaceutical company. The Company is engaged in the discovery, development, manufacture and sale of a broad line of pharmaceutical products for treating chronic autoimmune diseases, virology and neurological disorders. On January 29, 2016, the company reported fourth quarter earnings of $1.13 per share which beat analyst estimates by $0.01. In the past year the company's stock is down 1% and is losing to the S&P 500, which has lost 0.3% in the same time frame.
Source: Seeking Alpha
Related Articles:
- 8 Select High-Yield S&P 500 Dividend Stocks
- A Winning Investment Strategy
- 7 Dividend Stocks With A 20% Yield In 20 Years
- 5 Industrial Strength Dividend Growth Stocks With Yields In Excess Of 3%
- Finding Low Risk Dividend Stocks
________________________________________________________________
Subscribe to:
Post Comments (Atom)
Popular Posts Last 30 Days
-
Showing resilience during a tough week was a group of stocks that has not been heard from much in the past two years. A group that has been ...
-
While these pharma stocks have steady cash flows and revenues, there’s still plenty of growth left in the tank from new drugs in development...
-
Do you ever wish your dividend stocks paid out monthly rather than quarterly? For income-oriented investors who cover their monthly expenses...
-
This company is one of the less risky mortgage REITs. We see preferred shares from it as having a risk rating of 2. The series C shares drop...
-
In bull markets, dividends become more or less irrelevant. When the Dow Jones Industrial Average traded above 14,000 in 2007, very few stoc...
-
After prices rising for nearly two straight years, volatility has returned to the oil patch in the past month. Investors can expect above-av...
-
Despite a strong year, the renewable power company has lost 20% of its value, which has pushed its dividend yield up to 7%. That lower price...
-
Add it all up, and things are starting to get tense. That leaves investors wondering where they can go for safety. After years of tech outpe...
-
Insiders bought 45,000 units last week: It's now at multi-year lows, and is 26% below analysts' lowest price target, and is selling ...
-
The yield is 9.55%, with 1.12X coverage that should improve in 2019. Management has raised the quarterly distribution 16 straight quarters. ...
0 comments
Post a Comment
Post a Comment